NeuroPace Inc. (NPCE)
NASDAQ: NPCE
· Real-Time Price · USD
13.08
0.53 (4.22%)
At close: May 09, 2025, 1:09 PM
4.22% (1D)
| Bid | 12.96 |
| Market Cap | 428.41M |
| Revenue (ttm) | 79.91M |
| Net Income (ttm) | -27.14M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -14.06 |
| Forward PE | -19.79 |
| Analyst | Buy |
| Ask | 13.13 |
| Volume | 120,568 |
| Avg. Volume (20D) | 230,937 |
| Open | 12.60 |
| Previous Close | 12.55 |
| Day's Range | 12.55 - 13.19 |
| 52-Week Range | 5.45 - 15.11 |
| Beta | 2.05 |
About NPCE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NPCE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NPCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NeuroPace Inc. is scheduled to release its earnings on May 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+9.11%
Neurospace shares are trading higher after UBS ini...
Unlock content with
Pro Subscription
5 months ago
+28.15%
Neuropace shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 sales guidance. Wells Fargo maintained an Overweight rating on the stock.
